The Effect of Metformin Use on Hypopharyngeal Squamous Cell Carcinoma in Diabetes Mellitus Patients

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-6083-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

STK33 Overexpression in Hypopharyngeal Squamous Cell Carcinoma: Possible Role in Tumorigenesis

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2017English

Impact of Tumor Dimensions and Lymph Node Density on the Survival of Patients With Hypopharyngeal Squamous Cell Carcinoma

Cancer Management and Research
Oncology
2018English

The Use of Metformin and Colorectal Cancer Incidence in Patients With Type II Diabetes Mellitus

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

Metformin Use and Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus

MVP Journal of Medical Sciences
2016English

149 Metformin as Adjuvant in PDT in Squamous Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Metformin in Treatment of Diabetes Mellitus

BMJ
1962English

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

JAMA - Journal of the American Medical Association
Medicine
2000English

microRNA-504 Inhibits Cancer Cell Proliferation via Targeting CDK6 in Hypopharyngeal Squamous Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy